Manufacturing APIs with Asian Supply Chains

May 31, 2019
Podcast > Manufacturing APIs with Asian Supply Chains

Pharmaceutical Technology Podcast:
Manufacturing APIs with Asian Supply Chains

by Dr. Stephen Houldsworth, Director, Global Small Molecules & Antibiotics Platforms

Pharmaceutical Technology, May 31, 2019


Dr. Stephen Houldsworth, Director, Global Small Molecules & Antibiotics Platforms, talks with Pharmaceutical Technology’s Managing Editor of Special Projects Kaylynn Chiarello-Ebner about CordenPharma’s response to recent news regarding Sartan drugs with carcinogenic impurities that were tracked back to various Asian sources, including the various concerns that the Pharma Industry needs to take into consideration and how price factors into these decisions.

Questions to be Addressed:

  1. Sartan drugs have been in the news recently because of carcinogenic impurities that were tracked back to various Asian sources. It was discovered that perhaps synthetic chemistry issues were not sufficiently taken into account when processes were changed. As an API supplier, what has been your company’s response to this issue?
  2. When discussing Asian supply chains, how does CordenPharma address these concerns?
  3. How does price factor into these decisions?

Listen to the Podcast